Skip to main content

Revelation Biosciences, Inc 8-K, filed Nov 5, 2026

Revelation Biosciences, Inc. (REVB)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Revelation Biosciences, Inc filed this 8-K on November 5, 2026.

Revelation Biosciences, Inc. reported $9.1 million in cash as of September 30, 2026 and, based on current operating plans and projections, believes it can fund operations into the second quarter of 2027; nine-month net loss was $9.6 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits